Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 17,703 shares at $33.13 ($586K) on 2020-11-06, disclosed to the SEC on 2020-11-10.
Open-market sale of $586k BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.13 | 362 | $12K | 2.0% |
| 2 | $33.13 | 2,738 | $91K | 15.5% |
| 3 | $33.13 | 2,738 | $91K | 15.5% |
| 4 | $33.06 | 735 | $24K | 4.1% |
| 5 | $33.06 | 5,565 | $184K | 31.4% |
| 6 | $33.06 | 5,565 |
| $184K |
| 31.4% |
| Total | $33.08 avg | 17,703 | $586K | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |